Search research articles
Contact Us
Filters
Showing results (111-120 of 156) with videos related to
Page
of 16
Sort By:
Scandinavian Journal of Urology and Nephrology
|
June 2, 2011
Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: evaluation of cardiovascular events in a randomized trial
Per Olov Hedlund, Robert Johansson, Jan Erik Damber, et al.
Scandinavian Journal of Urology
|
December 3, 2014
Length of life gained with surgical treatment of prostate cancer: A population-based analysis
Martin Andreas Røder, Klaus Brasso, Ea Rusch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 21, 2013
Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort
Signe Benzon Larsen, Klaus Brasso, Peter Iversen, et al.
Cancer Medicine
|
December 15, 2017
Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries
Mathias Meijer, Lau Caspar Thygesen, Anders Green, et al.
Clinical Chemistry and Laboratory Medicine
|
June 22, 2012
Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses
David Ulmert, Andrew J Vickers, Howard I Scher, et al.
Scandinavian Journal of Urology and Nephrology
|
November 30, 2006
Bicalutamide 150 mg in addition to standard care for patients with early non-metastatic prostate cancer: updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years
Peter Iversen, Jan-Erik Johansson, Pär Lodding, et al.
Journal of Neurochemistry
|
March 15, 2011
Synthesis of neurotransmitter GABA via the neuronal tricarboxylic acid cycle is elevated in rats with liver cirrhosis consistent with a high GABAergic tone in chronic hepatic encephalopathy
Renata Leke, Lasse K Bak, Peter Iversen, et al.
Acta Oncologica (Stockholm, Sweden)
|
August 21, 2013
Changes in preoperative characteristics in patients undergoing radical prostatectomy--a 16-year nationwide analysis
Martin Andreas Røder, Klaus Brasso, Ib Jarle Christensen, et al.
Cancer
|
May 4, 2018
Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts
John T Helgstrand, Martin A Røder, Nina Klemann, et al.
Synapse (New York, N.Y.)
|
February 18, 2006
Distribution of PK11195 binding sites in porcine brain studied by autoradiography in vitro and by positron emission tomography
Paul Cumming, Mads D Pedersen, Luciano Minuzzi, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 156) with videos related to
Sort By:
Page
of 16
Scandinavian Journal of Urology and Nephrology
|
June 2, 2011
Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: evaluation of cardiovascular events in a randomized trial
Per Olov Hedlund, Robert Johansson, Jan Erik Damber, et al.
Scandinavian Journal of Urology
|
December 3, 2014
Length of life gained with surgical treatment of prostate cancer: A population-based analysis
Martin Andreas Røder, Klaus Brasso, Ea Rusch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 21, 2013
Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort
Signe Benzon Larsen, Klaus Brasso, Peter Iversen, et al.
Cancer Medicine
|
December 15, 2017
Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries
Mathias Meijer, Lau Caspar Thygesen, Anders Green, et al.
Clinical Chemistry and Laboratory Medicine
|
June 22, 2012
Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses
David Ulmert, Andrew J Vickers, Howard I Scher, et al.
Scandinavian Journal of Urology and Nephrology
|
November 30, 2006
Bicalutamide 150 mg in addition to standard care for patients with early non-metastatic prostate cancer: updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years
Peter Iversen, Jan-Erik Johansson, Pär Lodding, et al.
Journal of Neurochemistry
|
March 15, 2011
Synthesis of neurotransmitter GABA via the neuronal tricarboxylic acid cycle is elevated in rats with liver cirrhosis consistent with a high GABAergic tone in chronic hepatic encephalopathy
Renata Leke, Lasse K Bak, Peter Iversen, et al.
Acta Oncologica (Stockholm, Sweden)
|
August 21, 2013
Changes in preoperative characteristics in patients undergoing radical prostatectomy--a 16-year nationwide analysis
Martin Andreas Røder, Klaus Brasso, Ib Jarle Christensen, et al.
Cancer
|
May 4, 2018
Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts
John T Helgstrand, Martin A Røder, Nina Klemann, et al.
Synapse (New York, N.Y.)
|
February 18, 2006
Distribution of PK11195 binding sites in porcine brain studied by autoradiography in vitro and by positron emission tomography
Paul Cumming, Mads D Pedersen, Luciano Minuzzi, et al.
Page
of 16